Skip to content

Encompass Health

US · EHC #1326 by market cap Listed 1970
122.48 -2.21 -1.77%
Live - 5344 symbols - heartbeat 297s ago · 2026-10-07 19:54
After-hours 122.40 -0.07%
Market cap
12.08B
P/B
4.65
EPS
5.54
Reader sentiment Are you bullish or bearish on EHC?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 8 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.3 percentage points.

Institutional ownership

Held by institutions
99.32% -0.32pp
Institutions
701 -8
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund78.94%
Hedge Fund11.38%
Public Company3.62%
Government Pension Fund1.84%
Private Company1.61%
Sovereign Wealth Fund1.17%
Individual/Insider0.82%
Insurance Company0.34%
Government0.20%

Top holders

BlackRock 10.63%
T. Rowe Price Group, Inc. 5.22%
Vanguard Capital Management, LLC 5.17%
Vanguard Portfolio Management, LLC 4.99%
Wellington Management Group 3.32%
State Street Global Advisors 3.23%
Citadel Advisors LLC 2.60%
AllianceBernstein 2.51%
Fuller & Thaler Asset Management, Inc. 2.49%
Two Sigma Investments, LP 2.30%

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 31 buys · 19 sells

NameRoleStake
Mark Tarr Chief Executive Officer 0.27%
Douglas Coltharp Chief Financial Officer 0.24%
Edmund Fay Senior Vice President 0.09%
John Darby General Counsel 0.08%
Andrew Price Chief Accounting Officer 0.07%
Patrick Tuer EVP & Chief Operating Officer 0.03%
Christopher Reidy Independent Director 0.02%
Elissa Charbonneau Chief Medical Officer 0.02%
Gregory Carmichael Independent Director 0.00%
Kevin O'Connor Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-30 Andrew Price Chief Accounting Officer Open Market Disposition -5,211 $120.93
2026-08-30 John Darby General Counsel Derivative Exercise and Sale -4,858 $35.06–121.09
2026-08-09 Douglas Coltharp Chief Financial Officer Open Market Disposition -18,869 $125.38
2026-08-09 Mark Tarr Chief Executive Officer Open Market Disposition -173,148 $125.46–126.06
2026-08-09 John Darby General Counsel Open Market Disposition -8,906 $125.95
2026-07-15 Christopher Reidy Independent Director Other Acquisition +340 $112.40
2026-07-15 Edward Christie Director Other Acquisition +259 $112.43
2026-07-14 Joan Herman Independent Director Other Acquisition +85 --
2026-07-14 Leslye Katz Independent Director Other Acquisition +85 --
2026-07-14 Nancy Schlichting Independent Director Other Acquisition +40 --
2026-07-14 Gregory Carmichael Independent Director Other Acquisition +29 --
2026-07-14 Cain Hayes Director Other Acquisition +4 --
2026-07-14 Kevin O'Connor Independent Director Other Acquisition +19 --
2026-07-14 Terrance Williams Independent Director Other Acquisition +29 --
2026-05-14 Douglas Coltharp Chief Financial Officer Derivative Exercise and Sale -27,694 $32.94–107.28
2026-05-10 Patrick Tuer EVP & Chief Operating Officer Open Market Disposition -682 $104.56
2026-05-06 Joan Herman Independent Director Other Acquisition +1,634 --
2026-05-06 Leslye Katz Independent Director Other Acquisition +1,634 --
2026-05-06 Nancy Schlichting Independent Director Other Acquisition +1,634 --
2026-05-06 Gregory Carmichael Independent Director Other Acquisition +1,634 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.